Radiotherapy Plus PCV vs Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Radiotherapy-PCV Versus Radiotherapy-Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicentre Analysis of the French POLA Cohort
Oncologist 2021 Feb 01;[EPub Ahead of Print], V Esteyrie, C Dehais, E Martin, C Carpentier, E Uro-Coste, D Figarella-Branger, C Bronniman, D Pouessel, DL Ciron, F Ducray, EC MoyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.